193 related articles for article (PubMed ID: 20865569)
1. [Serum ghrelin, IL-6 and TNF-α levels in patients with chronic obstructive pulmonary disease.].
Deveci Y; Deveci F; Ilhan N; Karaca I; Turgut T; Muz MH
Tuberk Toraks; 2010; 58(2):162-72. PubMed ID: 20865569
[TBL] [Abstract][Full Text] [Related]
2. The effects of cachexia and related components on pulmonary functions in patients with COPD.
Görek Dilektaşli A; Ulubay G; Bayraktar N; Eminsoy I; Oner Eyüboğlu F
Tuberk Toraks; 2009; 57(3):298-305. PubMed ID: 19787469
[TBL] [Abstract][Full Text] [Related]
3. [Circulating leptin and ghrelin in patients with chronic obstructive pulmonary disease].
Peng M; Cai BQ; Ma Y; Zhu HJ; Sun Q; Song AL
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):182-5. PubMed ID: 17572996
[TBL] [Abstract][Full Text] [Related]
4. The role of serum leptin and tumor necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients.
Yang YM; Sun TY; Liu XM
Chin Med J (Engl); 2006 Apr; 119(8):628-33. PubMed ID: 16635406
[TBL] [Abstract][Full Text] [Related]
5. Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients.
Uzum AK; Aydin MM; Tutuncu Y; Omer B; Kiyan E; Alagol F
Eur J Intern Med; 2014 Apr; 25(4):364-9. PubMed ID: 23523152
[TBL] [Abstract][Full Text] [Related]
6. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters.
Calikoglu M; Sahin G; Unlu A; Ozturk C; Tamer L; Ercan B; Kanik A; Atik U
Respiration; 2004; 71(1):45-50. PubMed ID: 14872110
[TBL] [Abstract][Full Text] [Related]
7. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
[TBL] [Abstract][Full Text] [Related]
8. Circulating ghrelin in patients with chronic obstructive pulmonary disease.
Luo FM; Liu XJ; Li SQ; Wang ZL; Liu CT; Yuan YM
Nutrition; 2005; 21(7-8):793-8. PubMed ID: 15975486
[TBL] [Abstract][Full Text] [Related]
9. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
10. Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease.
Ju CR; Chen RC
Respir Med; 2012 Jan; 106(1):102-8. PubMed ID: 21840694
[TBL] [Abstract][Full Text] [Related]
11. Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement.
Koehler F; Doehner W; Hoernig S; Witt C; Anker SD; John M
Int J Cardiol; 2007 Jun; 119(1):83-9. PubMed ID: 17064790
[TBL] [Abstract][Full Text] [Related]
12. Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients.
Kayacan O; Karnak D; Beder S; Güllü E; Tutkak H; Senler FC; Köksal D
Am J Clin Oncol; 2006 Aug; 29(4):328-35. PubMed ID: 16891858
[TBL] [Abstract][Full Text] [Related]
13. [Trophologic insufficiency and absorptive function of small intestine in patients with chronic obstructive pulmonary disease].
Beloborodova EI; Akimova LA; Asanova AV; Cherniavskaia GM; Burkovskaia VA; Ustiuzhanina EA; Semenenko EV; Naumova EL
Klin Med (Mosk); 2009; 87(3):59-63. PubMed ID: 19469260
[TBL] [Abstract][Full Text] [Related]
14. [Body mass index and serum and sputum TNF-alpha levels relation in asthma and COPD].
Başyiğit I; Yildiz F; Yildirim E; Boyaci H; Ilgazli A
Tuberk Toraks; 2004; 52(3):256-61. PubMed ID: 15351939
[TBL] [Abstract][Full Text] [Related]
15. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
16. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
17. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients.
Crul T; Spruit MA; Gayan-Ramirez G; Quarck R; Gosselink R; Troosters T; Pitta F; Decramer M
Eur J Clin Invest; 2007 Nov; 37(11):897-904. PubMed ID: 17883420
[TBL] [Abstract][Full Text] [Related]
18. Circulating visfatin in chronic obstructive pulmonary disease.
Liu X; Ji Y; Chen J; Li S; Luo F
Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239
[TBL] [Abstract][Full Text] [Related]
19. [The effect of glucocorticoid on IL-8 expressing in lung tissue of rat with chronic obstructive pulmonary disease].
Zhang Y; Yang SR; Cheng DY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):287-90. PubMed ID: 17441351
[TBL] [Abstract][Full Text] [Related]
20. Determinants of BMI in patients with COPD.
Karadag F; Karul AB; Cildag O; Altun C; Gurgey O
Respirology; 2004 Mar; 9(1):70-5. PubMed ID: 14982605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
